During the most recent 90-day period, previous to the date of this filing, there have been 8 transactions reported to the SEC, all of which have been sales and have resulted in the disposition of 116,796 company shares by insiders. In the preceding 90-day window of time, there were 5 transactions from 4 insiders that resulted in the net acquisition of 1,568,090 shares.
This is lower than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 65.7 transactions per company, and disposition of 7,183 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1720580/000120919121038758/xslF345X03/doc4.xml
|--DCP Midstream Keeps Quarterly Distribution at $0.3...|
|Intel Likely to Top Q4 Sales Consensus, Raise 2022 O...|
|Customers Bancorp Reports Higher Q4 Core Earnings, R...|
|Crane Q4 Adjusted Earnings, Sales Gains Top Expectat...|
|-- Earnings Flash (CUBI) CUSTOMERS BANCORP Posts Q4 ...|